Appeals court grants another company a stay of US FDA’s marketing denial order

A US court has granted another stay request to a company that sued the US Food and Drug Administration (FDA) after the agency issued a marketing denial order (MDO) for its flavoured vaping products.

Chicago-based Gripum LLC asked for the denial of its premarket tobacco product application (PMTA) to be overturned and the US Court of Appeals for the Seventh Circuit has now granted a stay while the order is being fully reviewed.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization